LOWER RISK OF HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS B PATIENTS TREATED WITH ENTECAVIR: A REACH-B ANALYSIS OF THE ENUMERATE STUDY

被引：0
|
作者：
Ahn, J. [1 ]
Nguyen, M. [2 ]
Lee, H. [3 ]
Lim, J. [4 ]
Pan, C. [5 ]
Te, H. [6 ]
Tran, T. [7 ]
Trinh, H. N. [8 ]
Lau, D. [9 ]
Chu, D. [10 ]
Min, A. [11 ]
Leduc, T. -S. [12 ]
Pillai, A. [13 ]
Bae, H. [14 ]
Do, S. [15 ]
Mannalithara, A. [2 ]
Lok, A. S. [16 ]
Kim, W. R. [2 ]
机构：
[1] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[2] Stanford Univ, Stanford, CA 94305 USA
[3] Tufts Univ, Boston, MA 02111 USA
[4] Yale Univ, New Haven, CT USA
[5] NYU Langone, New York, NY USA
[6] Univ Chicago, Chicago, IL 60637 USA
[7] Cedars Sinai, Los Angeles, CA USA
[8] San Jose Gastroenterol, San Jose, CA USA
[9] Beth Israel Deaconess Med Ctr, Boston, MA USA
[10] Albert Einstein Coll Med, New York, NY USA
[11] Mt Sinai Beth Israel, New York, NY USA
[12] Leduc Med Grp Inc, Fountain Valley, CA USA
[13] Emory Univ, Atlanta, GA 30322 USA
[14] St Vincents Med Ctr, Los Angeles, CA USA
[15] Digest Hlth Associates Texas, Plano, TX USA
[16] Univ Michigan, Ann Arbor, MI 48109 USA
来源：
JOURNAL OF HEPATOLOGY | 2015年 / 62卷
关键词：
D O I：
10.1016/S0168-8278(15)30851-5
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P0646
引用
收藏
页码：S562 / S562
页数：1
相关论文
共 50 条
  • [41] Remaining hepatocellular carcinoma risk in chronic hepatitis B patients receiving entecavir/tenofovir in South Korea
    Yu, Jung Hwan
    Jin, Young-Joo
    Lee, Jin-Woo
    Lee, Don-Haeng
    HEPATOLOGY RESEARCH, 2018, 48 (11) : 862 - 871
  • [42] Impact of tenofovir alafenamide vs. entecavir on hepatocellular carcinoma risk in patients with chronic hepatitis B
    Hye Won Lee
    Young Youn Cho
    Hyein Lee
    Jae Seung Lee
    Seung Up Kim
    Jun Yong Park
    Do Young Kim
    Sang Hoon Ahn
    Beom Kyung Kim
    Soo Young Park
    Hepatology International, 2021, 15 : 1083 - 1092
  • [43] Mortality, Liver Transplantation, and Hepatocellular Carcinoma Among Patients With Chronic Hepatitis B Treated With Entecavir vs Lamivudine
    Lim, Young-Suk
    Han, Seungbong
    Heo, Nae-Yun
    Shim, Ju Hyun
    Lee, Han Chu
    Suh, Dong Jin
    GASTROENTEROLOGY, 2014, 147 (01) : 152 - 161
  • [44] Is HBeAg Seroconversion a Valid Surrogate Marker for Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated with Lamivudine or Entecavir?
    An, Jihyun
    Kim, Hwa Jung
    Lim, Young-Suk
    Suh, Dong Jin
    HEPATOLOGY, 2014, 60 : 998A - 998A
  • [45] No Difference in Incidence of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Virus Infection Treated With Entecavir vs Tenofovir
    Oh, Hyunwoo
    Yoon, Eileen L.
    Jun, Dae Won
    Ahn, Sang Bong
    Lee, Hyo-Young
    Jeong, Jae Yoon
    Kim, Hyoung Su
    Jeong, Soung Won
    Kim, Sung Eun
    Shim, Jae-Jun
    Sohn, Joo Hyun
    Cho, Yong Kyun
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 18 (12) : 2793 - +
  • [46] Medication Nonadherence Increases Hepatocellular Carcinoma, Cirrhotic Complications, and Mortality in Chronic Hepatitis B Patients Treated With Entecavir
    Shin, Jung Woo
    Jung, Seok Won
    Lee, Seung Bum
    Lee, Byung Uk
    Park, Bo Ryung
    Park, Eun Ji
    Park, Neung Hwa
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 (07): : 998 - 1008
  • [47] Comparison of incidence of hepatocellular carcinoma between chronic hepatitis B patients with cirrhosis treated with entecavir or tenofovir in Taiwan - a retrospective study
    Chen, Chien-Hung
    Chen, Chi-Yi
    Wang, Jing-Houng
    Lai, Hsueh-Chou
    Hung, Chao-Hung
    Lu, Sheng-Nan
    Peng, Cheng-Yuan
    AMERICAN JOURNAL OF CANCER RESEARCH, 2020, 10 (11): : 3882 - +
  • [48] Prediction of Hepatocellular Carcinoma in Entecavir treated Patients: Results from 744 Chronic Hepatitis B patients in a European Multicenter Study (VIRGIL)
    Arends, Pauline
    Zoutendijk, Roeland
    Carey, Ivana
    Brown, Ashley S.
    Fasano, Massimo
    Mutimer, David J.
    Deterding, Katja
    Reijnders, Jurrien G.
    Oo, Ye H.
    Petersen, Joerg
    van Boemmel, Florian
    de Knegt, Robert J.
    Berg, Thomas
    Welzel, Tania M.
    Santantonio, Teresa
    Hansen, Bettina E.
    Wedemeyer, Heiner
    Buti, Maria
    Pradat, Pierre
    Zoulim, Fabien
    Janssen, Harry L.
    HEPATOLOGY, 2013, 58 : 663A - 663A
  • [49] Tenofovir Treatment Has Lower Risk of Hepatocellular Carcinoma than Entecavir Treatment in Patients with Chronic Hepatitis B: A Systematic Review and Meta-Analysis
    Liu, Hairong
    Shi, Yu
    Hayden, John C.
    Ryan, Paul M.
    Rahmani, Jamal
    Yu, Guangsheng
    LIVER CANCER, 2020, 9 (04) : 468 - 476
  • [50] Hepatocellular carcinoma and death and transplantation in chronic hepatitis B treated with entecavir or tenofovir disoproxil fumarate
    Yeonjung Ha
    Young Eun Chon
    Mi Na Kim
    Joo Ho Lee
    Seong Gyu Hwang
    Scientific Reports, 10
12345